Concepedia

Yuki Yoshino

YY

Statistics

Publications

15

Citations

510

H-Index

13

Active since

2000

Affiliations

Tohoku University(Current)

Tohoku University Hospital

Tohoku Medical and Pharmaceutical University

Institute of Aging

Tokyo Medical University Hachioji Medical Center

Yuki Yoshino is an author at Tohoku University specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2000–2023

15

Publications

15

DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells

Yuriko Saiki, Yuki Yoshino, Hiroko Fujimura et al. · Biochemical and Biophysical Research Communications · 2012 · 114 citations

, , +7

<i>In vitro</i> treatment of human transforming growth factor‐β<sub>1</sub>‐treated monocyte‐derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction

Setsuya Aiba, Hideaki Manome, Yuki Yoshino et al. · Immunology · 2000 · 78 citations · Full text

, , +22

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells

Yuki Yoshino, Chikashi Ishioka · Scientific Reports · 2015 · 74 citations · Full text

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

Hidekazu Takahashi, Masanobu Takahashi, Shinobu Ohnuma et al. · BMC Cancer · 2017 · 32 citations · Full text

S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells

Hitoshi Sekine, Na Chen, Keisuke Sato et al. · Biochemical and Biophysical Research Communications · 2012 · 31 citations

, , +9

1–5 of 15